Seizures is a brain disorder characterized by a sudden, uncontrolled electrical disturbance in the brain. It involves changes in behavior, body movements or feelings, and consciousness levels of a patient. Partial-onset seizures also known as focal seizures is a subtype of seizures which is characterized by seizures at localized, one-side of the brain. According to CDC, in 2015, 1.2% of the US population has active epilepsy. This is about 3 million adults and 470,000 children. Also partial-onset seizures account for about 60% of all epileptic seizures. Drug therapies are preferred in the treatment of partial-onset seizures. Oral and injectable anticonvulsant agents are used in the effective treatment of partial-onset seizures.
Request Free Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4708
Partial-onset Seizures Market: Segmentation
The partial-onset seizures market can be segmented into indication, drug type, distribution channels and geography.
Based on indication, the global partial-onset seizures market is segmented as:
Simple Focal Seizures
Complex Focal Seizures
Secondary Generalized Seizures
Based on drug class, the global partial-onset seizures market is segmented as:
First-line Anti-epileptics
Carbamazepine
Lamotrigine
Levetiracetam
Oxcarbazepine
Sodium Valproate
Adjunctive Anti-epileptics
Clobazam
Gabapentin
Topiramate
Based on generation of drug, the global partial-onset seizures market is segmented as:
First Generation Anti-epileptics
Second Generation Anti-epileptics
Third Generation Anti-epileptics
Based on the distribution channels, the global partial-onset seizures market is segmented as:
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Online Pharmacies
Have Any Query? Ask our Industry Experts- https://www.factmr.com/connectus/sample?flag=AE&rep_id=4708
Regional analysis includes
North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, and Rest of Latin America)
Europe (Germany, Italy, U.K, Spain, France, Russia and Rest of Europe)
South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)
East Asia (China, South Korea, Japan)
Oceania (Australia, New Zealand)
Middle East and Africa (GCC, S. Africa, Turkey, and Rest Of MEA)
Partial-onset Seizures Market: Key Players
The global market for partial-onset seizures is consolidated with large number of market players. Examples of some of the primary key players operating in the global partial-onset seizures market are GlaxoSmithKline plc., Pfizer Inc., Abbott Laboratories, Novartis AG, Mylan N.V., Eisai Co., Ltd., SK Life Science Inc. Aprecia Pharmaceuticals, Dr. Reddy’s Labs Ltd., Cipla, Lupin Ltd., and among others.
Pertinent aspects this study on the Partial-Onset Seizures market tries to answer exhaustively are:
• What is the forecast size (revenue/volumes) of the most lucrative regional market?
• What is the share of the dominant product/technology segment in the Partial-Onset Seizures market?
• What regions are likely to witness sizable investments in research and development funding?
• What are Covid 19 implication on Partial-Onset Seizures market and learn how businesses can respond, manage and mitigate the risks?
• Which countries will be the next destination for industry leaders in order to tap new revenue streams?
• Which new regulations might cause disruption in industry sentiments in near future?
• Which is the share of the dominant end user?
• Which region is expected to rise at the most dominant growth rate?
• Which technologies will have massive impact of new avenues in the Partial-Onset Seizures market?
• Which key end-use industry trends are expected to shape the growth prospects of the Partial-Onset Seizures market?
• What factors will promote new entrants in the Partial-Onset Seizures market?
• What is the degree of fragmentation in the Partial-Onset Seizures market, and will it increase in coming years?
Request Free Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4708
Partial-onset Seizures Market: Segmentation
The partial-onset seizures market can be segmented into indication, drug type, distribution channels and geography.
Based on indication, the global partial-onset seizures market is segmented as:
Simple Focal Seizures
Complex Focal Seizures
Secondary Generalized Seizures
Based on drug class, the global partial-onset seizures market is segmented as:
First-line Anti-epileptics
Carbamazepine
Lamotrigine
Levetiracetam
Oxcarbazepine
Sodium Valproate
Adjunctive Anti-epileptics
Clobazam
Gabapentin
Topiramate
Based on generation of drug, the global partial-onset seizures market is segmented as:
First Generation Anti-epileptics
Second Generation Anti-epileptics
Third Generation Anti-epileptics
Based on the distribution channels, the global partial-onset seizures market is segmented as:
Hospital Pharmacies
Drug Stores
Retail Pharmacies
Online Pharmacies
Have Any Query? Ask our Industry Experts- https://www.factmr.com/connectus/sample?flag=AE&rep_id=4708
Regional analysis includes
North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, and Rest of Latin America)
Europe (Germany, Italy, U.K, Spain, France, Russia and Rest of Europe)
South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)
East Asia (China, South Korea, Japan)
Oceania (Australia, New Zealand)
Middle East and Africa (GCC, S. Africa, Turkey, and Rest Of MEA)
Partial-onset Seizures Market: Key Players
The global market for partial-onset seizures is consolidated with large number of market players. Examples of some of the primary key players operating in the global partial-onset seizures market are GlaxoSmithKline plc., Pfizer Inc., Abbott Laboratories, Novartis AG, Mylan N.V., Eisai Co., Ltd., SK Life Science Inc. Aprecia Pharmaceuticals, Dr. Reddy’s Labs Ltd., Cipla, Lupin Ltd., and among others.
Pertinent aspects this study on the Partial-Onset Seizures market tries to answer exhaustively are:
• What is the forecast size (revenue/volumes) of the most lucrative regional market?
• What is the share of the dominant product/technology segment in the Partial-Onset Seizures market?
• What regions are likely to witness sizable investments in research and development funding?
• What are Covid 19 implication on Partial-Onset Seizures market and learn how businesses can respond, manage and mitigate the risks?
• Which countries will be the next destination for industry leaders in order to tap new revenue streams?
• Which new regulations might cause disruption in industry sentiments in near future?
• Which is the share of the dominant end user?
• Which region is expected to rise at the most dominant growth rate?
• Which technologies will have massive impact of new avenues in the Partial-Onset Seizures market?
• Which key end-use industry trends are expected to shape the growth prospects of the Partial-Onset Seizures market?
• What factors will promote new entrants in the Partial-Onset Seizures market?
• What is the degree of fragmentation in the Partial-Onset Seizures market, and will it increase in coming years?
Comments
Post a Comment